Previous Article | Next Article ![]()
Molecular and Cellular Biology, May 2001, p. 2981-2990, Vol. 21, No. 9
Liggins Institute, School of Medicine,
University of Auckland, Auckland, New Zealand1;
Division of Molecular Life Sciences, Department of Life
Science, Pohang University of Science and Technology, Pohang, South
Korea2; Trescowthick Research
Laboratories, Peter MacCallum Cancer Institute, Melbourne,
Australia3; and Cellular Signalling
Laboratory, Department of Anatomical Sciences, University of Bologna,
Bologna, Italy4
Received 29 November 2000/Returned for modification 29 December
2000/Accepted 5 February 2001
It is well established that a phosphoinositide (PI) cycle which is
operationally distinct from the classical plasma membrane PI cycle
exists within the nucleus, where it is involved in both cell
proliferation and differentiation. However, little is known about the
regulation of the nuclear PI cycle. Here, we report that
nucleus-localized phospholipase C (PLC)
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.9.2981-2990.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Phosphorylation of Nuclear Phospholipase C
1 by
Extracellular Signal-Regulated Kinase Mediates the Mitogenic Action of
Insulin-Like Growth Factor I
1, the key enzyme for the
initiation of this cycle, is a physiological target of extracellular
signal-regulated kinase (ERK). Stimulation of Swiss 3T3 cells with
insulin-like growth factor I (IGF-I) caused rapid nuclear translocation
of activated ERK and concurrently induced phosphorylation of nuclear
PLC
1, which was completely blocked by the MEK inhibitor PD 98059. Coimmunoprecipitation detected a specific association between the
activated ERK and PLC
1 within the nucleus. In vitro studies
revealed that recombinant PLC
1 could be efficiently phosphorylated
by activated mitogen-activated protein kinase but not by PKA. The ERK
phosphorylation site was mapped to serine 982, which lies within a PSSP
motif located in the characteristic carboxy-terminal tail of PLC
1.
In cells overexpressing a PLC
1 mutant in which serine 982 is
replaced by glycine (S982G), IGF-I failed to activate the nuclear PI
cycle, and its mitogenic effect was also markedly attenuated.
Expression of S982G was found to inhibit ERK-mediated phosphorylation
of endogenous PLC
1. This result suggests that ERK-evoked
phosphorylation of PLC
1 at serine 982 plays a critical role in the
activation of the nuclear PI cycle and is also crucial to the mitogenic
action of IGF-I.
*
Corresponding author. Mailing address: Liggins
Institute, School of Medicine, University of Auckland, Private Bag
92019, 85 Park Rd., Auckland, New Zealand. Phone: 64 9 373 7599, ext.
4489. Fax: 64 9 373 7492. E-mail:
s.gilmour{at}auckland.ac.nz.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|